The business intelligence report titled ‘Global Proteomics Market - Analysis By Component (Instruments, Reagents, Services), Application (Clinical Diagnostic, Drug Discovery, Others), End User, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)’, available with MarketStudyReport, global proteomics market which amassed a valuation of USD 3.49 billion in 2020 is anticipated to generate strong returns by 2026.

Augmentation in R&D activities, technological advancements, and increase in government funding are the major factors fueling global proteomics market growth.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4026313/  

Further, penetration of the biomarker identifier process and notable developments in mass spectrometry based proteomics, in congruence with proliferation in nano proteomics, and increasing focus on producing personalized components may provide lucrative opportunities for market expansion in the upcoming years.

Despite the positive outlook, issues such as lack of skilled professionals, expensive nature of components, and a stringent regulatory landscape may threaten the growth trajectory of the industry during the analysis period.

On the other hand, the imperative role of proteins in segregating heathy individuals and diseased ones, and advent of mass spec technologies that aid in the stabilization of ions may uncover newer avenues for market growth during the forecast timeframe.

The worldwide proteomics market is fragmented in terms of component, application spectrum, end user and region. The research literature thoroughly analyzes key aspects pertaining to historical and current trends, along with growth prospects of each segment, to facilitate a broader understanding of market behavior among readers and maximize profit margins.

From a regional frame of reference, North America accounted for nearly 50.32% industry share   in 2020. This development can be attributed to increase in government funds directed towards research & development of novel therapeutics, growing inclination towards personalized medicines, escalating demand for superior quality research tools to accelerate data reproducibility, penetration of newer technologies such as structure-based drug design, and the prevalence of prominent players within the region.

The competitive terrain of global proteomics business sphere is influenced by key players such as Promega Corporation, WuXi AppTec, Eurofins Scientific, GE Healthcare, Bruker Corporation, Agilent Technologies Inc., QIAGEN N.V., Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc. and Merck KGaA.